Regenity Biosciences

Happy Holidays from Team Regenity! As 2024 comes to a close, we want to take a moment to wish you a joyful holiday season and a bright year ahead. This time of year reminds us to reflect and express our gratitude to our incredible team, customers and partners who make our mission possible. This year has been filled with milestones and the dedication of those who make a #MaterialDifference every day. From achieving significant regulatory approvals to delivering innovative solutions for patients, collaboration has driven our success, enabling us to serve more than four million patients this year with our technologies. Looking ahead to 2025, we’re excited about the opportunities to innovate, grow, and continue making an impact together. Wishing you and your loved ones health, happiness, and success in the year to come!

At Regenity Biosciences, we’re passionate about advancing regenerative solutions that change lives. That's why we're thrilled to see Daniel M. Ammon featured in Orthopedic Design & Technology Magazine, highlighting the game-changing potential of RejuvaKnee, our latest innovation for meniscal repair. Dan shares his perspective on the unmet needs in this space and how Regenity is setting a new standard by combining cutting-edge science with patient-first innovation. Want to know more about how RejuvaKnee is shaping the future? Check out the article and share your thoughts in the comments! https://lnkd.in/eatdhYW5

This month marks two years since Collagen Matrix acquired Polyganics, transforming into Regenity Biosciences and establishing our Polymer Center of Excellence in Groningen, The Netherlands. Over the past two years, we've been hard at work advancing innovation, including the upcoming launch of an IDE study in the U.S. later this year. This progress wouldn’t be possible without our talented and dedicated team, whose daily efforts make a real impact on patient care. We're thrilled to unveil our new look, a proud symbol of our brand and commitment. Looking ahead, we’re excited to continue bringing innovative solutions from this Center of Excellence to enhance patient lives worldwide!

Team Regenity is Hiring! It's a great time to join our expanding business. We currently have open roles for the following positions: -Sr. R&D Scientist -PT Temporary Marketing Manager, Meniscus -Technical Director, Collagen Operations -Technical Marketing Manager To apply for these positions, please visit: https://lnkd.in/expYkZ85. We look forward to hearing from you!

Join our esteemed colleague, Susan McGoff-Miller, Head of Human Resources at Regenity Biosciences, as she participates in a panel discussion on "Addressing the Shortage of Skilled Labor," presented by the Société Program Committee. This virtual event includes a panel of business leaders who are actively engaged in hiring and managing talent within their organizations. They will examine the extent and nature of the skilled labor shortage and share effective solutions to address this challenge, including the impact of evolving work processes and AI technology.   Date: Thursday, October 24, 2024 Time: 1:00 PM - 2:00 PM ET Visit https://www.societe.org to register. #SkilledLabor #HumanResources #RegenityBiosciences #WorkforceDevelopment

Our team is pumped to be participating in the Advanced Manufacturing Expo in Minneapolis today and tomorrow. As the trusted contract development and manufacturing partner for the medtech community, we collaborate closely with medical device partners to bring innovation from concept to reality. Join us at the expo to discover how our expertise in biomaterials, regulatory and manufacturing is accelerating the pace of regenerative innovation! #AdvancedManufacturingExpo #RegenityBiosciences #RegenerativeMedicine #materialdifference

Milestone moment! Regenity Marks 60th 510(k) Clearance with RejuvaKnee™ Meniscal Repair Implant! We’re delighted to announce that our groundbreaking meniscal repair implant has received FDA 510(k) clearance! This achievement represents our unwavering commitment to advancing orthopedic solutions and delivering innovative, patient-focused care. Meniscectomy can offer high short-term clinical success rates but can frequently lead to follow-on meniscectomy or predisposition for osteoarthritis, as opposed to RejuvaKnee™, which is designed to elongate the life of a knee that has been impacted by meniscal injury.  This approval is a testament to the hard work and dedication of our incredible team, whose relentless drive for excellence will set new standards in the field of meniscal repair. Learn more via our press release. https://lnkd.in/e_igzG8s

We’re thrilled to have Bill Messer, VP of Commercial Operations, and Scott Salvatoriello, Director of Sales, at the North American Spine Association Annual Meeting in Chicago! Join us in Meeting Room #5007 for an in-depth discussion on our advanced bone grafting and nerve repair solutions. Get an exclusive preview of our next-generation innovations, designed to advance healing in spine and orthopedic procedures. We’re dedicated to pushing the boundaries of regenerative medicine to improve patient outcomes. #NASS2024 #AdvancedBoneGrafting #InnovativeHealing

We are looking forward to participating in the 14th Orthopaedic Summit Evolving Techniques (OSET) Course & Investor Day Event later this week in Las Vegas, where we will showcase our latest breakthrough innovation: the RejuvaKnee™ meniscal repair implant. This device, pending US FDA 510(k) clearance, has the potential to revolutionize meniscal repair by enabling the regeneration of the patient’s own native meniscus. We are actively exploring commercial partnerships to bring this to life in the US market upon clearance. Please reach out to Jessica Swanson if interested in setting up some time to connect at OSET. #regenerativemedicine #meniscalrepairsurgery #innovation #materialdifference

We are thrilled to announce that Regenity Biosciences has received regulatory approval in China for our collagen dental membrane following a first-of-its-kind, Level 1 randomized clinical study! This approval marks a significant achievement as it represents our first dental product approved in China, and showcases the effectiveness of our membrane in periodontal regeneration. We're proud to expand our regenerative product offerings in China, continuing our mission to improve patient lives worldwide! #RegenerativeMedicine #DentalInnovation #ChinaApproval #OralHealth #ClinicalTrials https://lnkd.in/gge-WJ22